Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis

Study acronym: CeV
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment increased: 60 → 70 participants
    • Eligibility criteria expanded, about 14 words
    • Publications: details revised at 11 of 11 entries
  2. Start date changed from estimate of Oct 1, 2025 to Oct 15, 2025v3
  3. Primary endpoint revised
    • Secondary endpoints revised (2)
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Study the impact of rTMS on walking ability in people with Multiple Sclerosis (MS) induced spastic paraparesis and moderate walking disability.
Trial Details
NCT Number NCT07159789
Lead Sponsor Clinique Neuro-Outaouais
Collaborators: University of Ottawa
Conditions
(from sponsor)		 Multiple Sclerosis
Related terms Multiple Sclerosis
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov